PRCT of FICB vs LAI for Hip Arthroscopy

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

46 participants

Study Classification

INTERVENTIONAL

Study Start Date

2013-03-31

Study Completion Date

2014-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

A prospective randomised controlled trial involving patients undergoing hip arthroscopy. Participants were randomised to receiving either Fascia Iliaca Compartment Block (FICB) or Local Anaesthetic Infiltration (LAI) of the portal tracts with local anaesthetic. Supplemental analgesia was also used in both groups on an on-demand basis. Pain level is assessed at 1,3,6, and 24 hours post surgery. The primary outcome measure was the post-operative level of pain as assessed by Numeric Pain Score 6 hours after surgery. Secondary outcome measures were the frequency and the dose of morphine and other medications consumed at 1 and 24 hours after surgery as well as any other adverse events relating to pain or medications used for pain relief in both the groups.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Low Concentration Local Anesthesia Fascia Iliaca Block for Total Hip Arthroplasty

NCT06102811

Arthroplasty, Replacement, Hip

RECRUITING NA

Analgesic Comparison of PENG/LFCN to FICB for Total Hip Arthroplasty

NCT05477641

Analgesia

UNKNOWN NA

PENG and LFCN Block Versus FIC Block for Multimodal Analgesia After Total Hip Replacement Surgery: a Retrospective Analysis Focused on Movement (Retro-PvF)

NCT06342102

Regional Anesthesia Block Regional Anesthesia Total Hip Replacement Surgery +1 more

COMPLETED

A Prospective Analysis of Preoperative Fascia Iliaca Block for Hip Arthroscopy

NCT02623361

Muscle Weakness | Patient Pain

COMPLETED PHASE4

Fascia Iliaca Compartment Block For Analgesia After Total Hip Arthroplasty

NCT01758497

Pain Disorder Sensory Deficit

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Femoroacetabular Impingement

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Procedure - FICB

Fascia Iliaca Block following Hip Arthroscopy - Drug - Levobupivacaine 0.125% - 40ml

Group Type EXPERIMENTAL

Fascia Iliaca Compartment Block (FICB)

Intervention Type PROCEDURE

Fascia Iliaca Compartment Block

Levobupivacaine

Intervention Type DRUG

Levobupivacaine 0.125% - 40ml

Procedure - LAI

Local Anaesthetic Infiltration following Hip Arthroscopy - Drug - Levobupivacaine 0.125% - 40ml

Group Type ACTIVE_COMPARATOR

Local Anaesthetic Infiltration (LAI)

Intervention Type PROCEDURE

Local Anaesthetic Infiltration (LAI) of the portal tracts

Levobupivacaine

Intervention Type DRUG

Levobupivacaine 0.125% - 40ml

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Fascia Iliaca Compartment Block (FICB)

Fascia Iliaca Compartment Block

Intervention Type PROCEDURE

Local Anaesthetic Infiltration (LAI)

Local Anaesthetic Infiltration (LAI) of the portal tracts

Intervention Type PROCEDURE

Levobupivacaine

Levobupivacaine 0.125% - 40ml

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients over the age of 18 years
* Primary elective hip arthroscopy on a native hip for combined soft tissue injuries and FAI pathology
* Able to read, write and communicate in English

Exclusion Criteria

* Patients who did not want to be involved in the Trial
* Unable to give informed consent
* Previous hip surgery
* Patients younger than 18 years of age
* Chronic opioids users
* Patients known to have an allergy or intolerance to local anaesthetic agents or none steroidal anti-inflammatory medications

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes